Publications

Learn more about our science.

April 2025

Preclinical discovery and characterization of EO-1022, a site-specific glycan-conjugated anti-HER3 vcMMAE ADC for treating solid tumors

All
Posters & Oral Presentations
Manuscripts

April 27, 2025

Posters & Oral Presentations

Preclinical discovery and characterization of EO-1022, a site-specific glycan-conjugated anti-HER3 vcMMAE ADC for treating solid tumors

Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025

Presenting Author: Thomas O'Hare

April 08, 2024

Posters & Oral Presentations

Therapeutic potential of a HER3 antibody-drug conjugate for the treatment of HER3-expressing cancers

Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024

Presenting Author: Thomas O'Hare

Track our progress

Check back often for our latest insights, or sign up for our mailing list to receive the have the latest news and publications from Elevation Oncology delivered to your inbox.